Bio-Reference Laboratories Inc  

(Public, NASDAQ:BRLI)   Watch this stock  
Find more results forreference
31.80
+1.17 (3.82%)
Real-time:   1:57pm GMT-4
NASDAQ real-time data - Disclaimer
Currency in USD
Range 30.48 - 31.80
52 week 18.29 - 32.86
Open 30.94
Vol / Avg. 620,576.00/450,162.00
Mkt cap 881.65M
P/E 20.41
Div/yield     -
EPS 1.56
Shares 27.72M
Beta 0.89
Inst. own 99%
Jun 6, 2013
Q2 2013 Bio-Reference Laboratories, Inc. Earnings Conference Call - 10:30am GMT-4 - Add to calendar
Jun 3, 2013
Q2 2013 Bio-Reference Laboratories, Inc. Earnings Release Add to calendar
May 20, 2013
Bio-Reference Laboratories, Inc. at UBS Global Healthcare Conference - Webcast
May 15, 2013
Bio-Reference Laboratories, Inc. at Bank of America Merrill Lynch Health Care Conference - Webcast
Feb 28, 2013
BioReference Laboratories Inc. 1st Quarter Fiscal Year 2013 Earnings Conference call - Webcast
Feb 28, 2013
Q1 2013 Bio-Reference Laboratories, Inc. Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '13) 2012
Net profit margin 5.37% 6.37%
Operating margin 9.77% 11.51%
EBITD margin - 14.02%
Return on average assets 10.78% 14.14%
Return on average equity 15.00% 20.22%
Employees 2,726 -
Carbon Disclosure Rating - -

Address

481 Edward H. Ross Drive
ELMWOOD PARK, NJ 07407
United States - Map
+1-201-7912600 (Phone)
+1-201-7911941 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Bio-Reference Laboratories, Inc. (Bio-Reference) is a clinical testing laboratory offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women�s health and correctional health care. The Company has a network f approximately 116 patient service centers located in the Northeast (primarily in New York metropolitan super-regional area) for collection of patient specimens. It conducts business in New York State counties, as well as in of New Jersey and Maryland as well as some parts of Pennsylvania, Delaware and Connecticut.

Officers and directors

Marc D. Grodman M.D. Chairman of the Board, President, Chief Executive Officer
Age: 61
Bio & Compensation  - Reuters
Sam Singer Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Director
Age: 69
Bio & Compensation  - Reuters
Howard Dubinett Chief Operating Officer, Executive Vice President, Director
Age: 61
Bio & Compensation  - Reuters
Joseph Benincasa Independent Director
Age: 63
Bio & Compensation  - Reuters
Harry Elias Independent Director
Age: 82
Bio & Compensation  - Reuters
Gary Lederman Esq. Independent Director
Age: 78
Bio & Compensation  - Reuters
John Roglieri M.D. Independent Director
Age: 73
Bio & Compensation  - Reuters